Atlas Trials

Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer

Clinical trial NCT01992952 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01992952
Sponsor
Velindre NHS Trust
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor Positive Breast Cancer
Start date
2014-05-07
Primary completion
2019-03-01
Enrollment
149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.